aid: actio-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/actio-biosciences.png
name: Actio Biosciences
description: Actio Biosciences is a San Diego-based clinical-stage biotechnology company developing
  precision medicines that translate insights from Mendelian (single-gene) genetics into treatments
  for both rare and common diseases. Its pipeline targets genetically defined conditions including
  KCNT1-related epilepsy and TRPV4-related Charcot-Marie-Tooth disease type 2C (CMT2C), following a
  strategy of expanding from rare indications into more prevalent diseases that share the same
  underlying biology. The company is backed by Canaan Partners. Actio publishes no developer or API
  surface; this profile captures its public identity and corporate web properties.
url: https://raw.githubusercontent.com/api-evangelist/actio-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Precision Medicine
- Genetics
- Rare Diseases
- Drug Discovery
- Pharmaceutical
apis: []
common:
- type: Website
  url: https://actiobiosciences.com/
- type: About
  url: https://actiobiosciences.com/about/
- type: Blog
  url: https://actiobiosciences.com/category/press-releases/
- type: PrivacyPolicy
  url: https://actiobiosciences.com/privacy
- type: TermsOfService
  url: https://actiobiosciences.com/terms-of-use
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence